About the Event
With venture funding tightening in the post-COVID landscape, efficiency has become more critical than ever. To make limited capital go further, companies must meet key development milestones swiftly and successfully—unlocking the next stages of funding through high-quality, timely data.
In this interactive webinar hosted by BioSpace, industry experts will explore actionable strategies for maintaining quality under financial pressure. Marina Galvani, VP of Scientific Strategy at Evotec, will share her deep expertise in integrated drug development. She will be joined by Josh Gillum, VP of Business Development at Evotec, who will provide insights drawn from his experience leading 16 INDs through to multiple mid-phase clinical trials.
Don’t miss this opportunity to engage directly with leaders in the field and gain valuable perspectives on how to navigate today’s challenging market. Live Q&A will be available throughout the session.
